Key result
Female sex linked to ~7% lower ischemic heart disease risk in newly treated hypertension.
Why the study?
Gender differences in ischemic heart disease risk according to healthcare utilization and medication adherence among newly treated hypertensive adults were not well understood.
Does healthcare utilization and medication adherence affect the risk of ischemic heart disease differently between men and women in newly treated hypertensive patients?
Cohort (n=23,135)
Does healthcare utilization and medication adherence affect the risk of ischemic heart disease differently between men and women in newly treated hypertensive patients?
Hazard Ratio: 0.93 (95% CI 0.88–1)
Medication nonadherence and excessive healthcare visits (>12 per year) are strong predictors of incident ischemic heart disease in newly treated hypertensive patients, with similar effects observed across both genders.
Similar adherence and utilization effects on IHD risk across genders in new hypertension; hypothesis-generating and requires prospective confirmation before guiding care.
We aimed to investigate gender differences in ischemic heart disease (IHD) according to healthcare utilization and medication adherence among newly treated Korean hypertensive adults. The National Sample Cohort version 2.0 of the National Health Insurance Service was used for analysis. Newly treated hypertensive patients ≥ 20 years and without IHD in 2002 were selected from a population that underwent health examination during 2003–2006. Of those patients, 11,942 men and 11,193 women were analyzed and followed up for 10 years. We determined the association between IHD and healthcare utilization and medication adherence using the Cox proportional hazards model. Hypertensive women patients had a lower risk of IHD than men patients (hazard ratio [HR] = 0.93, 95% confidence interval [CI] 0.88–1.00). The IHD risk was increased in patients who visited healthcare providers > 12 times/person-year (HR = 2.97, 95% CI 2.79–3.17), paid high out-of-pocket expense/person-year (HR = 1.55, 95% CI 1.41–1.69), and had medication nonadherence (HR = 1.67, 95% CI 1.58–1.77). However, the risk was decreased in patients who used both urban and rural areas (HR 0.75, 95% CI 0.67–0.84) and mixed types of providers (HR = 0.93, CI 0.88–0.99). The risk of IHD was significantly different between men and women only in the visiting frequency to healthcare providers (men, HR = 3.21, 95% CI 2.93–3.52; women, HR = 2.78, 95% CI 2.53–3.04, p for interaction = 0.0188). In summary, the risk of IHD was similar according to healthcare utilization and medication adherence between men and women, except visiting frequency to healthcare providers.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2021) conducted a cohort in Hypertension (n=23,135). Female gender vs. Male gender was evaluated on Incidence of ischemic heart disease (HR 0.93, 95% CI 0.88-1.00). Among newly treated hypertensive patients, women had a lower overall risk of ischemic heart disease than men (HR 0.93), with the impact of healthcare utilization and medication adherence on risk being similar across genders except for visit frequency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: